Literature DB >> 13110037

Therapeutic trial of the synthetic heparin analogue dextran sulphate.

C R RICKETTS, K W WALTON, B D VAN LEUVEN, A BIRBECK, A BROWN, A C KENNEDY, C C BURT.   

Abstract

Entities:  

Keywords:  ANTICOAGULANTS; DEXTRAN

Mesh：

Substances：

Year:  1953        PMID： 13110037     DOI： 10.1016/s0140-6736(53)91306-3

Source DB:  PubMed          Journal:  Lancet        ISSN： 0140-6736            Impact factor:   79.321


× No keyword cloud information.
  10 in total

1.  Alopecia following treatment with dextran sulphate and other anticoagulant drugs.

Authors:  G R TUDHOPE; H COHEN; R W MEIKLE
Journal:  Br Med J       Date:  1958-05-03

2.  Duration of anticoagulant effect in relation to urinary excretion of dextran sulphate.

Authors:  S M JEAVONS; C R RICKETTS; K W WALTON
Journal:  Br Med J       Date:  1956-11-03

3.  Dextran sulphate: use as an anticoagulant, and action in lowering serum cholesterol.

Authors:  H COHEN; G R TUDHOPE
Journal:  Br Med J       Date:  1956-11-03

4.  Preparation of dextran [35S] sulphate and tracer experiments in the rabbit.

Authors:  C R RICKETTS; K W WALTON; S M SADDINGTON
Journal:  Biochem J       Date:  1954-12       Impact factor: 3.857

5.  The blood anticoagulant effect of short chain-length dextran sulphates.

Authors:  C R RICKETTS
Journal:  Br J Pharmacol Chemother       Date:  1954-06

6.  Investigation of the toxicity of a series of dextran sulphates of varying molecular weight.

Authors:  K W WALTON
Journal:  Br J Pharmacol Chemother       Date:  1954-03

7.  ANNOTATIONS.

Authors: 
Journal:  Br Med J       Date:  1956-11-17

8.  ESTIMATION OF THE LOW-DENSITY (BETA) LIPOPROTEINS OF SERUM IN HEALTH AND DISEASE USING LARGE MOLECULAR WEIGHT DEXTRAN SULPHATE.

Authors:  K W WALTON; P J SCOTT
Journal:  J Clin Pathol       Date:  1964-11       Impact factor: 3.411

9.  Chronic toxicity of dextran sulphate in rabbits.

Authors:  H C HINT; A W RICHTER
Journal:  Br J Pharmacol Chemother       Date:  1958-06

10.  Pharmacokinetics, toxicity, and activity of intravenous dextran sulfate in human immunodeficiency virus infection.

Authors:  C Flexner; P A Barditch-Crovo; D M Kornhauser; H Farzadegan; L J Nerhood; R E Chaisson; K M Bell; K J Lorentsen; C W Hendrix; B G Petty
Journal:  Antimicrob Agents Chemother       Date:  1991-12       Impact factor: 5.191
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.